Literature DB >> 12500197

Dominant negative MORT1/FADD rescues mice from CD95 and TNF-induced liver failure.

Marcus Schuchmann1, Eugene E Varfolomeev, Frank Hermann, Felix Rueckert, Dennis Strand, Heinz Koehler, Susanne Strand, Ansgar W Lohse, David Wallach, Peter R Galle.   

Abstract

Derangement of the apoptotic program is considered an important cause of liver disease. It became clear that receptor-mediated apoptosis is of specific interest in this context, and CD95 and CD120a, both members of the tumor necrosis factor (TNF) receptor superfamily, are the most prominent cell death receptors involved. The death signal is induced upon ligand binding by recruitment of caspases via the adapter molecule MORT1/FADD to the receptor and their subsequent activation. To investigate the role of MORT1/FADD in hepatocyte apoptosis, we generated transgenic mice expressing liver-specific dominant negative mutant. Mice looked grossly normal; breeding and liver development were not different compared with wild-type littermates. Expression of the transgene completely protected animals from liver failure induced by the anti-Fas antibody Jo2, whereas control animals died as expected 3 to 6 hours after i.p. injection of 15 microg antibody from acute hemorrhagic liver failure. Histology demonstrated only moderate inflammatory changes in the transgenic animals, whereas severe hemorrhagic hepatitis was observed in controls. Similar results were obtained in a model of TNF-mediated liver failure, in which transgenic animals survived significantly better than wild-type animals. In conclusion, our experiments provide evidence that MORT1/FADD is indispensable for Fas and TNF-mediated hepatic injury. This is not only of great importance for targeting future therapies for liver disease but might also serve as an intriguing model to study other causes of liver injury.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12500197     DOI: 10.1053/jhep.2003.50011

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  11 in total

1.  The role of death effector domain-containing proteins in acute oxidative cell injury in hepatocytes.

Authors:  Jörn M Schattenberg; Marcus A Wörns; Tim Zimmermann; You-Wen He; Peter R Galle; Marcus Schuchmann
Journal:  Free Radic Biol Med       Date:  2012-03-08       Impact factor: 7.376

2.  MORT1/FADD is involved in liver regeneration.

Authors:  Marcus Schuchmann; Felix Ruckert; Jose F Garcia-Lazaro; Andrea Karg; Jurgen Burg; Natalia Knorr; Jurgen Siebler; Eugene E Varfolomeev; David Wallach; Wolfgang Schreiber; Ansgar W Lohse; Peter R Galle
Journal:  World J Gastroenterol       Date:  2005-12-14       Impact factor: 5.742

3.  Enhanced sensitivity to CD95-induced apoptosis in ob/ob mice.

Authors:  Juergen Siebler; Markus Schuchmann; Susanne Strand; Hans A Lehr; Markus F Neurath; Peter R Galle
Journal:  Dig Dis Sci       Date:  2007-04-06       Impact factor: 3.199

4.  Protective effects of HFE7A, mouse anti-human/mouse Fas monoclonal antibody against acute and lethal hepatic injury induced by Jo2.

Authors:  Hiroko Yoshida; Kenji Watanabe; Shu Takahashi; Kimihisa Ichikawa
Journal:  Cytotechnology       Date:  2009-12-19       Impact factor: 2.058

5.  K1 protein of human herpesvirus 8 suppresses lymphoma cell Fas-mediated apoptosis.

Authors:  Suizhao Wang; Shu Wang; Hoyoung Maeng; Daniel P Young; Om Prakash; Luis E Fayad; Anas Younes; Felipe Samaniego
Journal:  Blood       Date:  2006-11-07       Impact factor: 22.113

6.  Mechanism of Fas signaling regulation by human herpesvirus 8 K1 oncoprotein.

Authors:  Zuzana Berkova; Shu Wang; Jillian F Wise; Hoyoung Maeng; Yuan Ji; Felipe Samaniego
Journal:  J Natl Cancer Inst       Date:  2009-03-10       Impact factor: 13.506

7.  Nucleolin inhibits Fas ligand binding and suppresses Fas-mediated apoptosis in vivo via a surface nucleolin-Fas complex.

Authors:  Jillian F Wise; Zuzana Berkova; Rohit Mathur; Haifeng Zhu; Frank K Braun; Rong-Hua Tao; Anita L Sabichi; Xue Ao; Hoyoung Maeng; Felipe Samaniego
Journal:  Blood       Date:  2013-04-18       Impact factor: 22.113

8.  Differential roles of JNK in ConA/GalN and ConA-induced liver injury in mice.

Authors:  Hong-Min Ni; Xiaoyun Chen; Wen-Xing Ding; Marcus Schuchmann; Xiao-Ming Yin
Journal:  Am J Pathol       Date:  2008-09-04       Impact factor: 4.307

9.  Lead increases lipopolysaccharide-induced liver-injury through tumor necrosis factor-alpha overexpression by monocytes/macrophages: role of protein kinase C and P42/44 mitogen-activated protein kinase.

Authors:  Yu-Jung Cheng; Bei-Chang Yang; Ming-Yie Liu
Journal:  Environ Health Perspect       Date:  2006-04       Impact factor: 9.031

10.  A20 prevents chronic liver inflammation and cancer by protecting hepatocytes from death.

Authors:  L Catrysse; M Farhang Ghahremani; L Vereecke; S A Youssef; C Mc Guire; M Sze; A Weber; M Heikenwalder; A de Bruin; R Beyaert; G van Loo
Journal:  Cell Death Dis       Date:  2016-06-02       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.